Breaking News Instant updates and real-time market news.

TEVA

Teva

$37.86

-0.29 (-0.76%)

08:09
11/30/16
11/30
08:09
11/30/16
08:09

Teva to present data on Granix, Treanda, Trisenox injections at ASH meeting

Teva announced that data on GRANIX Injection, TREANDA Injection and TRISENOX Injection will be presented during poster sessions at the 2016 ASH Annual Meeting to be held at the San Diego Convention Center in San Diego, CA on December 3-6, 2016. Additional bendamustine abstracts were also accepted for publication in an online issue of Blood to be issued during the annual meeting. "We look forward to sharing real world data and outcomes research from our Oncology portfolio that provide deeper insights into our products," said Richard Nieman, M.D., SVP, Global Medical Affairs, Teva Pharmaceuticals. "The presentations at this year's ASH Meeting further highlight Teva's commitment to providing innovative medicines that positively impact our healthcare system, treatment and management of disease, and the lives of people, particularly those affected by cancer."

  • 03

    Apr

TEVA Teva
$37.86

-0.29 (-0.76%)

11/16/16
11/16/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Sysco (SYY) downgraded to Neutral from Outperform at Credit Suisse with analyst Edward Kelly saying Sysco shares are up 50% over the last 18 months and now views risk/reward as balanced. 2. Teva (TEVA) downgraded to Hold from Buy at Jefferies, to Equal Weight from Overweight at Morgan Stanley, and to Neutral from Buy at BTIG. 3. Bank of America (BAC) Capital One (COF) downgraded to Neutral from Outperform at Baird while the firm downgraded Fifth Third (FITB) to Underperform from Neutral. 4. Zions Bancorp (ZION) downgraded to Equal Weight from Overweight at Morgan Stanley and to Market Perform from Outperform at Bernstein. 5. Yingli Green Energy (YGE) downgraded to Sell from Buy at Axiom while the firm downgraded SolarCity (SCTY) and JA Solar (JASO) to Sell from Hold. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/17/16
MAXM
11/17/16
NO CHANGE
Target $52
MAXM
Buy
Teva price target lowered to $52 from $72 at Maxim
Maxim analyst Gabrielle Zhou lowered her price target for Teva to $52 from $72 after the company reported Q3 results and cut it full-year guidance. The analyst notes that the company has started its Actavis integration, with the latter now contributing to Teva's generic revenues. However, she believes Teva needs to focus now on growth, noting that 2017 will be a challenge. Zhou reiterates a Buy rating on Teva's shares.
11/22/16
LEER
11/22/16
NO CHANGE
LEER
Outperform
Alder Biopharmaceuticals patent fight far from over, says Leerink
Leerink analyst Joseph Schwartz says Alder Biopharmaceuticals (ALDR) stated that the European Patent Office issued a ruling revoking all claims in its competitor Teva's (TEVA) patent relating to CGRP antagonist antibodies but maintaining and narrowing claims relating to the use of CGRP antagonist antibodies in human therapy to the prevention or treatment of headache such as migraine and cluster headache. The analyst notes that the persistence of the headache claims has concerned investors, but points out that Alder believes the patent fight is far from over in the EU, or moreover in the U.S. Schwartz reiterates an Outperform rating on Alder's shares.
11/25/16
PIPR
11/25/16
NO CHANGE
Target $47
PIPR
Overweight
Alder recent selloff an overreaction, says Piper Jaffray
Piper Jaffray analyst Charles Duncan attributes the recent weakness in shares of Alder Biopharmaceuticals (ALDR) to "increased visibility and outcome uncertainty" for the company's challenge to Teva's (TEVA) anti-CGRP patents in the U.S. and Europe. The analyst views the selloff as an overreaction and remains focused on his "clinical data-driven thesis for the emerging, differentiated profile of lead candidate ALD403." Duncan keeps an Overweight rating on Alder with a $47 price target.

TODAY'S FREE FLY STORIES

BPMC

Blueprint Medicines

$27.01

-0.99 (-3.54%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Blueprint Medicines to hold a conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

CBS

CBS

$60.18

-0.39 (-0.64%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
CBS management to meet with JPMorgan »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 12

    Dec

PLNT

Planet Fitness

$20.02

0.03 (0.15%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Planet Fitness management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 09

    Jan

RMBS

Rambus

$12.76

0.09 (0.71%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Rambus participates in a conference call with JPMorgan »

JPMorgan Alternative…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
UBS economists and strategists hold an analyst/industry conference call »

U.S. Equity &…

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
ISM Non-Mfg Index Composite to be reported at 10:00 »

November ISM Non-Mfg…

JCI

Johnson Controls

$45.32

-0.41 (-0.90%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Johnson Controls to hold a meeting »

Strategic Review &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

CNDT

Conduent

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Conduent to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

VCRA

Vocera

$17.96

0.07 (0.39%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Vocera management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Barclays commodities/energy analysts hold an analyst/industry conference call »

Commodities Analysts…

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
Breaking General news story  »

Chicago Federal Reserve…

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Juno Therapeutics to host analyst and investor meeting »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

TKPPY

Technip

$17.80

0.45 (2.59%)

, FTI

FMC Technologies

$35.60

0.9 (2.59%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
FMC Technologies to host special shareholder meeting »

Special Shareholder…

TKPPY

Technip

$17.80

0.45 (2.59%)

FTI

FMC Technologies

$35.60

0.9 (2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

TGTX

TG Therapeutics

$5.50

0.05 (0.92%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
TG Therapeutics to hold an investor and analyst reception »

In connection with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
JPMorgan Euro & global equity strategist holds analyst/industry conference call »

European & Global…

CSV

Carriage Services

$27.50

0.21 (0.77%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Carriage Services management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
Breaking General news story  »

Chicago Federal Reserve…

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

GNMSF

Genmab

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Genmab to hold data review meeting »

Management discusses data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

RHHBY

Roche

$27.20

-0.1 (-0.37%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Roche to hold an analyst meeting »

Analyst Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

04:55
12/05/16
12/05
04:55
12/05/16
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

BSFT

BroadSoft

$40.30

-0.35 (-0.86%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
BroadSoft to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

CLF

Cliffs Natural

$9.56

0.32 (3.46%)

04:55
12/05/16
12/05
04:55
12/05/16
04:55
Conference/Events
Cliffs Natural management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.